Juan Antonio Guerra

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.

Rocio García‐Carbonero, Manuel Hidalgo, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 1997 · 86 citations

Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors

José María Serrano Sanz, Iria González, Silvia del Castillo et al. · The Oncologist · 2015 · 78 citations · Full text

Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients

Beatriz Losada, Juan Antonio Guerra, Diego Malón et al. · Clinical & Translational Oncology · 2018 · 65 citations

Breast Oncology, Medicine, Pretreatment Neutrophil/lymphocyte +7

Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Miguel Quintela-Fandiño, Serafín Morales, Alfonso Cortés-Salgado et al. · Clinical Cancer Research · 2019 · 43 citations

Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study

Mafalda Oliveira, Claudette Falato, Juan Miguel Cejalvo et al. · Annals of Oncology · 2023 · 37 citations · Full text